Page 1 | Search Results | Diabetes | American Diabetes Association

1-19 of 19

Sort by

Sort Order Select

Meeting Abstracts

851-P: Whole Body Digital Twin (WBDT) Enabled Diabetes Reversal—U.S. Real-World Findings

LISA SHAH, SHASHANK R. JOSHI, JAHANGIR MOHAMMED, MALUK MOHAMED, MOHAMED THAJUDEEN, FRANCINE R. KAUFMAN, BREE WILLIS

Diabetes 2024;73(Supplement_1):851-P

https://doi.org/10.2337/db24-851-P

Published: 14 June 2024

View article titled, 851-P: Whole Body Digital Twin (WBDT) Enabled Diabetes Reversal—U.S. Real-World Findings

Meeting Abstracts

1806-LB: Improvement in Sensory Function and Achieving Remission of Type 2 Diabetes Mellitus through Digital Twin Technology—A One-Year Intervention Study

PARAMESH SHAMANNA, MALA DHARMALINGAM, ARUN VADAVI, ASHOK KESHAVAMURTHY, SUCHITRA BHONSLEY, MALUK MOHAMED, LISA SHAH, MOHAMED THAJUDEEN, MAHIKA PANANDIKAR, SHASHANK R. JOSHI

Diabetes 2024;73(Supplement_1):1806-LB

https://doi.org/10.2337/db24-1806-LB

Published: 14 June 2024

View article titled, 1806-LB: Improvement in Sensory Function and Achieving Remission of Type 2 Diabetes Mellitus through Digital Twin Technology—A One-Year Intervention Study

Meeting Abstracts

20-OR: Digital Twin (DT) Technology in Type 2 Diabetes Remission and Glycemic Improvement—Eighteen Months Results from a Randomized Controlled Trial

PARAMESH SHAMANNA, MALA DHARMALINGAM, ARUN VADAVI, ASHOK KESHAVAMURTHY, SUCHITRA BHONSLEY, MOHAMED THAJUDEEN, ASMIN SHA, SHASHANK R. JOSHI

Diabetes 2024;73(Supplement_1):20-OR

https://doi.org/10.2337/db24-20-OR

Published: 14 June 2024

View article titled, 20-OR: Digital Twin (DT) Technology in Type 2 Diabetes Remission and Glycemic Improvement—Eighteen Months Results from a Randomized Controlled Trial

Meeting Abstracts

1363-P: Diabetes Control and Complications in West India—Three-Year Results of LANDMARC Trial

SHASHANK R. JOSHI, BIPIN SETHI, AMBIKA GOPALAKRISHNAN UNNIKRISHNAN, MANOJ S. CHAWLA, SONALI A. PATANGE, TEJAS SHAH, AMEYA S. JOSHI, RUTUL GOKALANI, PRAMOD D. GANDHI, SHALINI K. MENON, ARVIND GADEKAR, DEEPA CHODANKAR

Diabetes 2024;73(Supplement_1):1363-P

https://doi.org/10.2337/db24-1363-P

Published: 14 June 2024

View article titled, 1363-P: Diabetes Control and Complications in West India—Three-Year Results of LANDMARC Trial

Meeting Abstracts

1-PUB: Impaired Kidney Function in Diabetic Patients—A Warning

BANSHI D. SABOO, AMIT GUPTA, SHASHANK R. JOSHI, JOTHYDEV KESHAVDEV, RAJA JOSHI, MANN N. PANCHOLI, RIA PATEL, SUPRIYA KALOO, GARIMA VERMA

Diabetes 2024;73(Supplement_1):1-PUB

https://doi.org/10.2337/db24-1-PUB

Published: 14 June 2024

View article titled, 1-PUB: Impaired Kidney Function in Diabetic Patients—A Warning

Meeting Abstracts

803-P: How Effective Is Weight Loss by Oral Semaglutide on Glycemic Control in a Real-World Setting?

JOTHYDEV KESAVADEV, ARUN SHANKAR, SHASHANK R. JOSHI, ASHA ASHIK, SHAHANA YASMIN, ANJANA BASANTH, SOURAV RAJ K, SUNITHA JOTHYDEV

Diabetes 2024;73(Supplement_1):803-P

https://doi.org/10.2337/db24-803-P

Published: 14 June 2024

View article titled, 803-P: How Effective Is Weight Loss by Oral Semaglutide on Glycemic Control in a Real-World Setting?

Meeting Abstracts

800-P: Post Hoc Analysis of Phase III Study of Liraglutide Biosimilar with Reference Biologic in Obese Type 2 Diabetes Mellitus Indians

SHASHANK R. JOSHI, HANMANT V. BARKATE, ABHISHEK MANE, JR., ANUP U. PETARE, SANJAY Y. CHOUDHARI

Diabetes 2024;73(Supplement_1):800-P

https://doi.org/10.2337/db24-800-P

Published: 14 June 2024

View article titled, 800-P: Post Hoc Analysis of Phase III Study of Liraglutide Biosimilar with Reference Biologic in Obese Type 2 Diabetes Mellitus Indians

Meeting Abstracts

1333-P: Diabetes Complications in Metropolitan vs. Nonmetropolitan Cities of India—Three-Year Follow-up Results of LANDMARC Trial

SANJAY KALRA, ASHOK K. DAS, SHASHANK R. JOSHI, AMBRISH MITHAL, K.M. PRASANNA KUMAR, AMBIKA GOPALAKRISHNAN UNNIKRISHNAN, HEMANT THACKER, BIPIN SETHI, SUBHANKAR CHOWDHURY, AMARNATH SUGUMARAN, ASHWINI SATPATHY, ARVIND GADEKAR, SHALINI K. MENON, RENUKA NEOGI, DEEPA CHODANKAR, CHIRAG TRIVEDI, SUBHASH KUMAR WANGNOO, ABDUL H. ZARGAR, NADEEM RAIS

Diabetes 2023;72(Supplement_1):1333-P

https://doi.org/10.2337/db23-1333-P

Published: 20 June 2023

View article titled, 1333-P: Diabetes Complications in Metropolitan vs. Nonmetropolitan Cities of India—Three-Year Follow-up Results of LANDMARC Trial

Meeting Abstracts

1423-P: Glycemic Status at Three-Year Follow-up in LANDMARC—Longitudinal Nationwide Study on Real-World Outcomes of Type 2 Diabetes in India

SHASHANK R. JOSHI, ASHOK K. DAS, K.M. PRASANNA KUMAR, AMBRISH MITHAL, SANJAY KALRA, AMBIKA GOPALAKRISHNAN UNNIKRISHNAN, HEMANT THACKER, BIPIN SETHI, SUBHANKAR CHOWDHURY, AMARNATH SUGUMARAN, ASHWINI SATPATHY, ARVIND GADEKAR, SHALINI K. MENON, RENUKA NEOGI, DEEPA CHODANKAR, CHIRAG TRIVEDI, SUBHASH KUMAR WANGNOO, ABDUL H. ZARGAR, NADEEM RAIS

Diabetes 2023;72(Supplement_1):1423-P

https://doi.org/10.2337/db23-1423-P

Published: 20 June 2023

View article titled, 1423-P: Glycemic Status at Three-Year Follow-up in LANDMARC—Longitudinal Nationwide Study on Real-World Outcomes of Type 2 Diabetes in India

Meeting Abstracts

1372-P: Micro and Macro Complications Three-Year Follow-up in LANDMARC—Longitudinal Nationwide Study on Real-World Outcomes of Type 2 Diabetes in India

NADEEM RAIS, ASHOK K. DAS, SHASHANK R. JOSHI, AMBRISH MITHAL, SANJAY KALRA, AMBIKA GOPALAKRISHNAN UNNIKRISHNAN, HEMANT THACKER, BIPIN SETHI, SUBHANKAR CHOWDHURY, AMARNATH SUGUMARAN, ASHWINI SATPATHY, ARVIND GADEKAR, SHALINI K. MENON, RENUKA NEOGI, DEEPA CHODANKAR, CHIRAG TRIVEDI, SUBHASH KUMAR WANGNOO, ABDUL H. ZARGAR, K.M. PRASANNA KUMAR

Diabetes 2023;72(Supplement_1):1372-P

https://doi.org/10.2337/db23-1372-P

Published: 20 June 2023

View article titled, 1372-P: Micro and Macro Complications Three-Year Follow-up in LANDMARC—Longitudinal Nationwide Study on Real-World Outcomes of Type 2 Diabetes in India

Meeting Abstracts

1427-P: Glycemic Trend in Metropolitan vs. Nonmetropolitan Cities of India—Three-Year Follow-up Results of LANDMARC

AMBIKA GOPALAKRISHNAN UNNIKRISHNAN, ASHOK K. DAS, SHASHANK R. JOSHI, AMBRISH MITHAL, SANJAY KALRA, K.M. PRASANNA KUMAR, HEMANT THACKER, BIPIN SETHI, SUBHANKAR CHOWDHURY, AMARNATH SUGUMARAN, ASHWINI SATPATHY, ARVIND GADEKAR, SHALINI K. MENON, RENUKA NEOGI, DEEPA CHODANKAR, CHIRAG TRIVEDI, SUBHASH KUMAR WANGNOO, ABDUL H. ZARGAR, NADEEM RAIS

Diabetes 2023;72(Supplement_1):1427-P

https://doi.org/10.2337/db23-1427-P

Published: 20 June 2023

View article titled, 1427-P: Glycemic Trend in Metropolitan vs. Nonmetropolitan Cities of India—Three-Year Follow-up Results of LANDMARC

Meeting Abstracts

1049-P: Pros and Cons of Telemedicine in Diabetes—Survey among Doctors and Allied HCPs

JOTHYDEV KESAVADEV, ARUN SHANKAR, BANSHI D. SABOO, SHASHANK R. JOSHI, ANJANA BASANTH, GOPIKA KRISHNAN, SUNITHA JOTHYDEV

Diabetes 2023;72(Supplement_1):1049-P

https://doi.org/10.2337/db23-1049-P

Published: 20 June 2023

View article titled, 1049-P: Pros and Cons of Telemedicine in Diabetes—Survey among Doctors and Allied HCPs

Meeting Abstracts

1435-P: Therapeutic Patterns at Three-Year Follow-up in LANDMARC—Longitudinal Nationwide Study on Real-World Outcomes of Type 2 Diabetes in India

HEMANT THACKER, ASHOK K. DAS, SHASHANK R. JOSHI, AMBRISH MITHAL, SANJAY KALRA, AMBIKA GOPALAKRISHNAN UNNIKRISHNAN, K.M. PRASANNA KUMAR, BIPIN SETHI, SUBHANKAR CHOWDHURY, AMARNATH SUGUMARAN, ASHWINI SATPATHY, ARVIND GADEKAR, SHALINI K. MENON, RENUKA NEOGI, DEEPA CHODANKAR, CHIRAG TRIVEDI, SUBHASH KUMAR WANGNOO, ABDUL H. ZARGAR, NADEEM RAIS

Diabetes 2023;72(Supplement_1):1435-P

https://doi.org/10.2337/db23-1435-P

Published: 20 June 2023

View article titled, 1435-P: Therapeutic Patterns at Three-Year Follow-up in LANDMARC—Longitudinal Nationwide Study on Real-World Outcomes of Type 2 Diabetes in India

Meeting Abstracts

440-P: Complications of Diabetes after 15 Years—Comparing Telemedicine with Conventional Care

JOTHYDEV KESAVADEV, ARUN SHANKAR, KRISHNADEV JOTHYDEV, SHASHANK R. JOSHI, GOPIKA KRISHNAN, GEETHU SANAL, ANJANA BASANTH, GOPIKA B. CHANDRAN, SUNITHA JOTHYDEV

Diabetes 2023;72(Supplement_1):440-P

https://doi.org/10.2337/db23-440-P

Published: 20 June 2023

View article titled, 440-P: Complications of Diabetes after 15 Years—Comparing Telemedicine with Conventional Care

Meeting Abstracts

221-LB: Normalisation of Glycemic and Extraglycemic Parameters with T2DM Remission—Insights from RCT Enabled by Whole-Body Digital Twin Technology

PARAMESH SHAMANNA, LISA SHAH, MALUK MOHAMED, JAHANGIR MOHAMMED, TERRENCE POON, MALA DHARMALINGAM, ARUN VADAVI, BANSHI SABOO, SURESH DAMODHARAN, ASHOK KESHAVAMURTHY, MOHAMED THAJUDEEN, SUCHITRA BHONSLEY, SHASHANK R. JOSHI

Diabetes 2022;71(Supplement_1):221-LB

https://doi.org/10.2337/db22-221-LB

Published: 01 June 2022

View article titled, 221-LB: Normalisation of Glycemic and Extraglycemic Parameters with T2DM Remission—Insights from RCT Enabled by Whole-Body Digital Twin Technology

Meeting Abstracts

26-OR: Metabolic Benefits beyond Glycemic Control with Artificial Intelligence, Internet of Things, and Whole-Body Digital Twin: Initial Six Months Results of a Randomized Control Trial

SHASHANK R. JOSHI, LISA SHAH, MALUK MOHAMED, JAHANGIR MOHAMMED, TERRENCE POON, MALA DHARMALINGAM, ARUN VADAVI, BANSHI SABOO, SURESH DAMODHARAN, ASHOK KESHAVAMURTHY, MOHAMED THAJUDEEN, SUCHITRA BHONSLEY, PARAMESH SHAMANNA

Diabetes 2022;71(Supplement_1):26-OR

https://doi.org/10.2337/db22-26-OR

Published: 01 June 2022

View article titled, 26-OR: Metabolic Benefits beyond Glycemic Control with Artificial Intelligence, Internet of Things, and Whole-Body Digital Twin: Initial Six Months Results of a Randomized Control Trial

Meeting Abstracts

4-LB: Remission of Type 2 Diabetes and Improvement in Metabolic Markers with the Twin Precision Treatment Technology (TPT) —A Multicenter, Randomized, Controlled Trial

PARAMESH SHAMANNA, LISA SHAH, JAHANGIR MOHAMMED, MALUK MOHAMED, TERRENCE POON, MALA DHARMALINGAM, BANSHI SABOO, SURESH DAMODHARAN, ARUN VADAVI, MOHAMED THAJUDEEN, ASHOK KESHAVAMURTHY, FRANCINE R. KAUFMAN, SHASHANK R. JOSHI

Diabetes 2022;71(Supplement_1):4-LB

https://doi.org/10.2337/db22-4-LB

Published: 01 June 2022

View article titled, 4-LB: Remission of Type 2 Diabetes and Improvement in Metabolic Markers with the Twin Precision Treatment Technology (TPT) —A Multicenter, Randomized, Controlled Trial

Meeting Abstracts

767-P: Effect of Digital Twin Technology for Remission of Diabetes on the Glycemic and Extra-Glycemic Parameters: Interim Results of the Prospective Randomised Controlled Clinical Trial

PARAMESH SHAMANNA, SHASHANK R. JOSHI, LISA SHAH, MALA DHARMALINGAM, ARUN VADAVI, JAHANGIR MOHAMMED, MALUK MOHAMED, TERRENCE POON, ASHOK KESHAVAMURTHY, MOHAMED THAJUDEEN, SUCHITRA BHONSLEY

Diabetes 2021;70(Supplement_1):767-P

https://doi.org/10.2337/db21-767-P

Published: 01 June 2021

View article titled, 767-P: Effect of Digital Twin Technology for Remission of Diabetes on the Glycemic and Extra-Glycemic Parameters: Interim Results of the Prospective Randomised Controlled Clinical Trial

Journal Articles

Type 2 Diabetes: Demystifying the Global Epidemic

Ranjit Unnikrishnan, Rajendra Pradeepa, Shashank R. Joshi, Viswanathan Mohan

Diabetes 2017;66(6):1432–1442

https://doi.org/10.2337/db16-0766

Published: 15 May 2017

View article titled, Type 2 Diabetes: Demystifying the Global Epidemic

NARROW

851-P: Whole Body Digital Twin (WBDT) Enabled Diabetes Reversal—U.S. Real-World Findings

1806-LB: Improvement in Sensory Function and Achieving Remission of Type 2 Diabetes Mellitus through Digital Twin Technology—A One-Year Intervention Study

20-OR: Digital Twin (DT) Technology in Type 2 Diabetes Remission and Glycemic Improvement—Eighteen Months Results from a Randomized Controlled Trial

1363-P: Diabetes Control and Complications in West India—Three-Year Results of LANDMARC Trial

1-PUB: Impaired Kidney Function in Diabetic Patients—A Warning

803-P: How Effective Is Weight Loss by Oral Semaglutide on Glycemic Control in a Real-World Setting?

800-P: Post Hoc Analysis of Phase III Study of Liraglutide Biosimilar with Reference Biologic in Obese Type 2 Diabetes Mellitus Indians

1333-P: Diabetes Complications in Metropolitan vs. Nonmetropolitan Cities of India—Three-Year Follow-up Results of LANDMARC Trial

1423-P: Glycemic Status at Three-Year Follow-up in LANDMARC—Longitudinal Nationwide Study on Real-World Outcomes of Type 2 Diabetes in India

1372-P: Micro and Macro Complications Three-Year Follow-up in LANDMARC—Longitudinal Nationwide Study on Real-World Outcomes of Type 2 Diabetes in India

1427-P: Glycemic Trend in Metropolitan vs. Nonmetropolitan Cities of India—Three-Year Follow-up Results of LANDMARC

1049-P: Pros and Cons of Telemedicine in Diabetes—Survey among Doctors and Allied HCPs

1435-P: Therapeutic Patterns at Three-Year Follow-up in LANDMARC—Longitudinal Nationwide Study on Real-World Outcomes of Type 2 Diabetes in India

440-P: Complications of Diabetes after 15 Years—Comparing Telemedicine with Conventional Care

221-LB: Normalisation of Glycemic and Extraglycemic Parameters with T2DM Remission—Insights from RCT Enabled by Whole-Body Digital Twin Technology

26-OR: Metabolic Benefits beyond Glycemic Control with Artificial Intelligence, Internet of Things, and Whole-Body Digital Twin: Initial Six Months Results of a Randomized Control Trial

4-LB: Remission of Type 2 Diabetes and Improvement in Metabolic Markers with the Twin Precision Treatment Technology (TPT) —A Multicenter, Randomized, Controlled Trial

767-P: Effect of Digital Twin Technology for Remission of Diabetes on the Glycemic and Extra-Glycemic Parameters: Interim Results of the Prospective Randomised Controlled Clinical Trial

Type 2 Diabetes: Demystifying the Global Epidemic

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

This Feature Is Available To Subscribers Only